NASDAQ:XENE - Xenon Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$13.50 -0.20 (-1.46 %)
(As of 09/19/2018 02:30 PM ET)
Previous Close$13.40
Today's Range$12.90 - $13.50
52-Week Range$2.10 - $15.92
Volume1,917 shs
Average Volume339,234 shs
Market Capitalization$270.62 million
P/E Ratio-7.59
Dividend YieldN/A
Beta0.85

Headlines

Xenon Pharmaceuticals (NASDAQ XENE) News Headlines

Source:
DateHeadline
Xenon Pharma closes $63M stock offeringXenon Pharma closes $63M stock offering
seekingalpha.com - September 17 at 5:17 PM
Xenon Pharmaceuticals Announces Closing of its $63.0 Million Public Offering of Common SharesXenon Pharmaceuticals Announces Closing of its $63.0 Million Public Offering of Common Shares
finance.yahoo.com - September 17 at 5:17 PM
Zacks: Analysts Anticipate Xenon Pharmaceuticals Inc (XENE) to Post -$0.47 Earnings Per ShareZacks: Analysts Anticipate Xenon Pharmaceuticals Inc (XENE) to Post -$0.47 Earnings Per Share
www.americanbankingnews.com - September 15 at 10:48 AM
Xenon Pharmaceuticals (XENE) Announces Proposed Public Offering of Common SharesXenon Pharmaceuticals (XENE) Announces Proposed Public Offering of Common Shares
www.streetinsider.com - September 13 at 4:53 PM
Xenon Pharmaceuticals prices $63M public offering of common sharesXenon Pharmaceuticals prices $63M public offering of common shares
seekingalpha.com - September 13 at 4:53 PM
Form 8-K Xenon Pharmaceuticals For: Sep 12Form 8-K Xenon Pharmaceuticals For: Sep 12
www.streetinsider.com - September 13 at 8:27 AM
Xenon Pharmaceuticals (XENE) to Acquire XEN1101 Milestones and Royalties from Bausch Health (BHC)Xenon Pharmaceuticals (XENE) to Acquire XEN1101 Milestones and Royalties from Bausch Health (BHC)
www.streetinsider.com - September 12 at 8:20 AM
Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 ProgramXenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program
finance.yahoo.com - September 11 at 8:24 AM
Xenon: An Updated Investment AnalysisXenon: An Updated Investment Analysis
seekingalpha.com - September 10 at 4:56 PM
Is Xenon Pharmaceuticals A Stock To Consider?Is Xenon Pharmaceuticals A Stock To Consider?
seekingalpha.com - September 8 at 8:18 AM
Xenon Pharma up 15% on new pipeline candidateXenon Pharma up 15% on new pipeline candidate
seekingalpha.com - September 7 at 5:06 PM
Xenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsyXenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsy
seekingalpha.com - September 6 at 8:26 AM
Xenon Pharmaceuticals (XENE) Plans XEN496 Pivotal Phase 3 Trial in mid-2019Xenon Pharmaceuticals (XENE) Plans XEN496 Pivotal Phase 3 Trial in mid-2019
www.streetinsider.com - September 6 at 8:26 AM
Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a “Phase 3 Ready” Potassium Channel Modulator for the Treatment of EpilepsyXenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a “Phase 3 Ready” Potassium Channel Modulator for the Treatment of Epilepsy
finance.yahoo.com - September 6 at 8:26 AM
Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a "Phase 3 Ready" Potassium Channel Modulator for the Treatment of EpilepsyXenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a "Phase 3 Ready" Potassium Channel Modulator for the Treatment of Epilepsy
feeds.benzinga.com - September 6 at 7:44 AM
Xenon Pharmaceuticals (XENE) Provides Financial Support For The Study Of The New Antiepileptic Drug XEN1101 - SlideshowXenon Pharmaceuticals (XENE) Provides Financial Support For The Study Of The New Antiepileptic Drug XEN1101 - Slideshow
seekingalpha.com - August 29 at 4:58 PM
Xenon Pharmaceuticals Inc (XENE) Expected to Post Earnings of -$0.47 Per ShareXenon Pharmaceuticals Inc (XENE) Expected to Post Earnings of -$0.47 Per Share
www.americanbankingnews.com - August 29 at 12:20 PM
Edited Transcript of XENE earnings conference call or presentation 7-Aug-18 8:30pm GMTEdited Transcript of XENE earnings conference call or presentation 7-Aug-18 8:30pm GMT
finance.yahoo.com - August 19 at 8:29 AM
Xenon Pharmaceuticals, Inc. (XENE) CEO Dr. Simon Pimstone on Q2 2018 Results - Earnings Call TranscriptXenon Pharmaceuticals, Inc. (XENE) CEO Dr. Simon Pimstone on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 5:06 PM
Xenon Pharmaceuticals: 2Q Earnings SnapshotXenon Pharmaceuticals: 2Q Earnings Snapshot
finance.yahoo.com - August 8 at 8:26 AM
Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue EstimatesXenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 8 at 8:26 AM
Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate UpdateXenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - August 7 at 5:24 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results and Provide Corporate UpdateXenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update
finance.yahoo.com - August 3 at 4:31 PM
Xenon Pharma inks $50M stock sales agreementXenon Pharma inks $50M stock sales agreement
seekingalpha.com - July 12 at 8:19 AM
Xenon Pharmaceuticals Announces At-The-Market Equity OfferingXenon Pharmaceuticals Announces At-The-Market Equity Offering
finance.yahoo.com - July 12 at 8:19 AM
A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The YearA Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year
feeds.benzinga.com - July 5 at 1:34 PM
Form SC 13G Xenon Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, LLCForm SC 13G Xenon Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, LLC
www.streetinsider.com - July 3 at 5:08 PM
Xenon Pharma +3.9% as Potiga gets orphan drug statusXenon Pharma +3.9% as Potiga gets orphan drug status
seekingalpha.com - June 25 at 5:37 PM
Benzingas Daily Biotech Pulse: vTv Swoons On Failed Alzheimers Trial, Regenxbio Gets FDA Fast Track For RGX-111Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111
feeds.benzinga.com - June 13 at 8:20 AM
Xenon Pharma continues northward march, up 15%Xenon Pharma continues northward march, up 15%
seekingalpha.com - June 12 at 5:03 PM
41 Stocks Moving In Tuesdays Mid-Day Session41 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - June 12 at 1:20 PM
Xenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare ConferenceXenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
finance.yahoo.com - June 1 at 5:43 PM
Reader Inquiry: Can The Run Up Continue For Xenon Pharmaceuticals?Reader Inquiry: Can The Run Up Continue For Xenon Pharmaceuticals?
seekingalpha.com - May 30 at 5:19 PM
Blog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat ConferenceBlog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat Conference
finance.yahoo.com - May 17 at 8:24 AM
Xenon Pharma (XENE) Presents XEN1101 Interim Phase 1 Data At 14th Eilat Conference - SlideshowXenon Pharma (XENE) Presents XEN1101 Interim Phase 1 Data At 14th Eilat Conference - Slideshow
seekingalpha.com - May 16 at 5:40 PM
Are Xenon Pharmaceuticals Shares Making a Run?Are Xenon Pharmaceuticals Shares Making a Run?
www.msn.com - May 15 at 5:48 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and OverviewXenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview
www.nasdaq.com - May 15 at 8:29 AM
Xenon Pharma up 21% premarket on positive XEN1101 dataXenon Pharma up 21% premarket on positive XEN1101 data
seekingalpha.com - May 15 at 8:29 AM
Xenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat ConferenceXenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat Conference
feeds.benzinga.com - May 15 at 6:39 AM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of ...Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of ...
globenewswire.com - May 14 at 5:19 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of XEN1101 and XEN901 Presentations at 14th Eilat ConferenceXenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of XEN1101 and XEN901 Presentations at 14th Eilat Conference
finance.yahoo.com - May 14 at 5:19 PM
Xenon Pharmaceuticals (XENE) CEO Simon Pimstone on Q1 2018 Results - Earnings Call TranscriptXenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 5:52 PM
Edited Transcript of XENE earnings conference call or presentation 8-May-18 8:30pm GMTEdited Transcript of XENE earnings conference call or presentation 8-May-18 8:30pm GMT
finance.yahoo.com - May 10 at 8:26 AM
Xenon Pharmaceuticals: 1Q Earnings SnapshotXenon Pharmaceuticals: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 8:20 AM
Xenon Pharma beats by $0.27Xenon Pharma beats by $0.27
seekingalpha.com - May 8 at 5:38 PM
Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate UpdateXenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - May 8 at 5:38 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results and Provide Corporate UpdateXenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results and Provide Corporate Update
finance.yahoo.com - May 1 at 5:17 PM
Xenon Pharmaceuticals to Present at the 2018 Bloom Burton & Co. Healthcare Investor ConferenceXenon Pharmaceuticals to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 25 at 5:28 PM
Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange ...Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange ...
globenewswire.com - March 30 at 5:29 PM
Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P.Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P.
finance.yahoo.com - March 28 at 5:17 PM
This page was last updated on 9/19/2018 by MarketBeat.com Staff

Featured Article: Ex-Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel